Ideal and Reality: Barricade in the Delivery of Small Interfering RNA for Cancer Therapy

Author(s): Di Wu, Haobo Han, Zhen Xing, Jianxu Zhang, Li Li, Wei Shi, Quanshun Li

Journal Name: Current Pharmaceutical Biotechnology

Volume 17 , Issue 3 , 2016

Become EABM
Become Reviewer
Call for Editor


Small interfering RNA (siRNA) has been demonstrated to be a powerful tool for silencing post-transcriptional gene expression, and thus exhibits great potential in cancer gene therapy. However, siRNA technology has not become an established strategy for cancer treatment, as it is a considerable challenge to deliver siRNA to the targeting sites. In this review, barricades in the systemic delivery of siRNA were systematically introduced, from pharmacokinetics, biodistribution and intracellular behavior. Meanwhile, current and potential strategies for overcoming the barricades were elucidated, including chemical modification of siRNA, nanomaterial-based delivery systems, and targeting and stimuli-responsive smart carriers. In conclusion, the siRNA-based gene silencing drug will gain an important position for treating human diseases if we can solve the gap between ideal and reality.

Keywords: siRNA, gene silencing, barricade, delivery system, smart carrier.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Page: [237 - 247]
Pages: 11
DOI: 10.2174/1389201017666151029110710
Price: $65

Article Metrics

PDF: 26